Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
hepatocellular-carcinomapembrolizumabradiotherapy
hepatocellular carcinoma, radiotherapy, pembrolizumab, tumor thrombosis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 832500
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.